Opus Genetics, Inc. (IRD) vs Orthofix Medical Inc. (OFIX)
A side-by-side comparison of Opus Genetics, Inc. and Orthofix Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRD
Opus Genetics, Inc.
$4.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OFIX
Orthofix Medical Inc.
$9.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IRD vs OFIX
growth of $100 · dividends reinvested · last 2yIRD +239.5% (+84.3%/yr)OFIX -41.4% (-23.5%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
IRD OFIX
IRD vs OFIX: by the numbers
- •OFIX is the larger company ($380M vs $362M market cap).
- •Both run net losses; OFIX's is the smaller (-7.41% vs -1091.82% net margin).
- •IRD grew revenue faster over the past five years (150.49% vs 12.83% CAGR).
Metrics side by side
Valuation
| Metric | IRD | OFIX |
|---|---|---|
| P/S ratio | 36.69 | 0.46 |
| P/B ratio | N/A | 0.89 |
| EV / EBITDA | N/A | 4.27 |
Profitability
| Metric | IRD | OFIX |
|---|---|---|
| Gross margin | 99.87% | 69.59% |
| Operating margin | -271.90% | -3.05% |
| Net margin | -1091.82% | -7.41% |
| ROE | N/A | -14.38% |
| ROIC | -59.29% | -3.55% |
Growth (annualized)
| Metric | IRD | OFIX |
|---|---|---|
| Revenue CAGR (5Y) | 150.49% | 12.83% |
| Total return CAGR (5Y) | N/A | -23.97% |
Frequently asked
- Which has grown faster, IRD or OFIX?
- Over the past five years, IRD grew revenue faster — IRD at a 150.49% CAGR versus OFIX at 12.83%.
Go deeper
Dig into the metrics
Opus Genetics ROEOrthofix Medical ROEOpus Genetics operating marginOrthofix Medical operating marginOpus Genetics revenue growthOrthofix Medical revenue growthOpus Genetics free cash flowOrthofix Medical free cash flow
Opus Genetics & Orthofix Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.